These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28207857)

  • 1. Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity.
    PLOS ONE Staff
    PLoS One; 2017; 12(2):e0172775. PubMed ID: 28207857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity.
    Lu J; Cui J; Li X; Wang X; Zhou Y; Yang W; Chen M; Zhao J; Pei G
    PLoS One; 2016; 11(11):e0166415. PubMed ID: 27835671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Gamma-Secretase-Dependent and -Independent Effects of Presenilin1 on β-Catenin·Tcf-4 Transcriptional Activity.
    Raurell I; Codina M; Casagolda D; Del Valle B; Baulida J; de Herreros AG; Duñach M
    PLoS One; 2016; 11(8):e0161515. PubMed ID: 27525417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias.
    Calon F; Dridi M; Hornykiewicz O; Bédard PJ; Rajput AH; Di Paolo T
    Brain; 2004 May; 127(Pt 5):1075-84. PubMed ID: 15033896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: NF-κB is activated in CD4+ iNKT cells by sickle cell disease and mediates rapid induction of adenosine A2A receptors.
    The
    PLoS One; 2015; 10(2):e0117760. PubMed ID: 25659149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease.
    Atack JR; Shook BC; Rassnick S; Jackson PF; Rhodes K; Drinkenburg WH; Ahnaou A; Te Riele P; Langlois X; Hrupka B; De Haes P; Hendrickx H; Aerts N; Hens K; Wellens A; Vermeire J; Megens AA
    ACS Chem Neurosci; 2014 Oct; 5(10):1005-19. PubMed ID: 25203719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Exploring the reproducibility of functional connectivity alterations in Parkinson's disease.
    Badea L; Onu M; Wu T; Roceanu A; Bajenaru O
    PLoS One; 2018; 13(5):e0197121. PubMed ID: 29723284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of Parkinson's disease--adenosine A2A receptor antagonists].
    Matsubara E; Shoji M; Abe K
    Nihon Rinsho; 2002 Jan; 60(1):112-6. PubMed ID: 11808320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Long-Latency Somatosensory Evoked Potentials of the Subthalamic Nucleus in Patients with Parkinson's Disease.
    Trenado C; Elben S; Friggemann L; Gruhn S; Groiss SJ; Vesper J; Schnitzler A; Wojtecki L
    PLoS One; 2017; 12(4):e0175602. PubMed ID: 28384357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of action of adenosine A2A receptor antagonists as symptomatic treatment for Parkinson's disease.
    Mori A
    Int Rev Neurobiol; 2014; 119():87-116. PubMed ID: 25175962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: S-Nitrosylation of G protein-coupled receptor kinase 6 and Casein kinase 2 alpha modulates their kinase activity toward alpha-synuclein phosphorylation in an animal model of Parkinson's disease.
    Wu W; Sung CC; Yu P; Li J; Chung KKK
    PLoS One; 2020; 15(6):e0235296. PubMed ID: 32555609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Acute and Chronic Sustained Hypoxia Do Not Substantially Regulate Amyloid-β Peptide Generation In Vivo.
    PLOS ONE Staff
    PLoS One; 2017; 12(7):e0181510. PubMed ID: 28746391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype.
    PLOS ONE Staff
    PLoS One; 2017; 12(4):e0176628. PubMed ID: 28445525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes.
    PLOS ONE Staff
    PLoS One; 2019; 14(1):e0210931. PubMed ID: 30640951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Motor planning error in Parkinson's disease and its clinical correlates.
    Kawasaki T; Mikami K; Kamo T; Aoki R; Ishiguro R; Nakamura H; Tozawa R; Asada N; Hiiragi Y; Yamada Y; Hirano M; Katsuki K
    PLoS One; 2020; 15(1):e0228698. PubMed ID: 31999803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Reduced Topological Efficiency in Cortical-Basal Ganglia Motor Network of Parkinson's Disease: A Resting State fMRI Study.
    Wei L; Zhang J; Long Z; Wu GR; Hu X; Zhang Y; Wang J
    PLoS One; 2018; 13(7):e0200623. PubMed ID: 29990373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice.
    Smith KM; Browne SE; Jayaraman S; Bleickardt CJ; Hodge LM; Lis E; Yao L; Rittle SL; Innocent N; Mullins DE; Boykow G; Reynolds IJ; Hill D; Parker EM; Hodgson RA
    Eur J Pharmacol; 2014 Apr; 728():31-8. PubMed ID: 24486705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: The related factors of sleep benefit in Parkinson's disease: A systematic review and meta-analysis.
    Zhong R; Chen Q; Zhang X; Zhang X; Lin W
    PLoS One; 2019; 14(5):e0216524. PubMed ID: 31042758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A(2A) adenosine receptors and Parkinson's disease severity.
    Casetta I; Vincenzi F; Bencivelli D; Corciulo C; Gentile M; Granieri E; Borea PA; Varani K
    Acta Neurol Scand; 2014 Apr; 129(4):276-81. PubMed ID: 24032478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A2A-receptor antagonism and pathophysiology of Parkinson's disease and drug-induced movement disorders.
    Kulisevsky J; Poyurovsky M
    Eur Neurol; 2012; 67(1):4-11. PubMed ID: 22134373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.